4.1 Oxidative stress

Oxidative stress is a central mechanism of toxicity. It describes the imbalance between reactive oxygen species (ROS) and the body's capacity to neutralize them. When ROS overwhelm antioxidant defenses, they damage lipids, proteins, and DNA, contributing to a wide range of diseases. For toxicologists, understanding oxidative stress explains how environmental chemicals, drugs, and lifestyle exposures translate into cellular harm.

Oxidative stress overview

Oxidative stress occurs when ROS production exceeds the cell's ability to detoxify these species or repair the damage they cause. This isn't just a background concept; it's a unifying mechanism that links diverse toxicant exposures to common downstream injuries like inflammation, mutation, and cell death.

Definition of oxidative stress

Oxidative stress is a state where ROS levels exceed the antioxidant defense capacity of the cell. The key idea is imbalance: it can result from too much ROS production, too little antioxidant defense, or both happening at once. The result is oxidative modification of cellular macromolecules that disrupts normal function.

Causes of oxidative stress

Endogenous sources of ROS are part of normal metabolism:

• The mitochondrial electron transport chain is the largest endogenous ROS source. Electrons occasionally "leak" from complexes I and III, partially reducing $O_2$ to superoxide ($O_2^{•-}$).
• NADPH oxidases (NOX enzymes) deliberately produce superoxide in specific cell types, particularly phagocytes during immune responses.
• Cytochrome P450 enzymes can generate ROS as byproducts during xenobiotic metabolism, which is especially relevant in toxicology.

Exogenous factors that induce oxidative stress include environmental toxicants (air pollution particulates, pesticides like paraquat), ionizing radiation, and certain medications (e.g., doxorubicin).

Lifestyle factors also matter: cigarette smoke is a potent exogenous ROS source, alcohol consumption increases hepatic ROS via CYP2E1 induction, and high-fat diets promote mitochondrial ROS overproduction. Chronic inflammation from any cause amplifies ROS generation through activated immune cells.

Free radicals in oxidative stress

Free radicals are atoms or molecules with one or more unpaired electrons, making them highly reactive. They drive the molecular damage that defines oxidative stress.

Types of free radicals

Reactive oxygen species (ROS):

• Superoxide anion ($O_2^{•-}$): The "parent" ROS, generated first in most pathways. Moderately reactive on its own but serves as a precursor to more damaging species.
• Hydroxyl radical ($OH^•$): The most reactive biological radical. It reacts almost instantly with whatever molecule is nearby.
• Hydrogen peroxide ($H_2O_2$): Technically not a free radical (no unpaired electron), but it's grouped with ROS because it generates $OH^•$ via metal-catalyzed reactions.

Reactive nitrogen species (RNS):

• Nitric oxide ($NO^•$): A signaling molecule at low concentrations, but damaging at high levels.
• Peroxynitrite ($ONOO^-$): Formed when $NO^•$ reacts with $O_2^{•-}$. A powerful oxidant that nitrates tyrosine residues on proteins.

Lipid-derived radicals include lipid peroxyl ($LOO^•$) and alkoxyl ($LO^•$) radicals, which propagate chain reactions in membranes.

Formation of free radicals

The main formation pathways to know:

1. Mitochondrial leak: Electrons escape the electron transport chain (mainly complexes I and III) and reduce $O_2$ to $O_2^{•-}$.
2. Enzymatic production: NOX enzymes transfer electrons from NADPH to $O_2$, generating $O_2^{•-}$. This is intentional in phagocytes (respiratory burst) but can be pathological elsewhere.
3. Xenobiotic metabolism: Cytochrome P450 enzymes can "uncouple," transferring electrons to $O_2$ instead of the substrate, producing ROS.
4. Fenton reaction: Transition metals catalyze $OH^•$ formation. For iron: $Fe^{2+} + H_2O_2 \rightarrow Fe^{3+} + OH^• + OH^-$. This is why free iron is so dangerous in biological systems.

Reactivity of free radicals

The unpaired electron makes free radicals seek out reaction partners aggressively. Hydroxyl radicals are so reactive they damage whatever molecule they encounter within a few angstroms of where they form. Superoxide and hydrogen peroxide are less reactive individually, but their real danger is serving as precursors to $OH^•$.

A critical concept here is chain reactions. In lipid peroxidation, one radical event generates new radicals, so a single initiating event can damage many molecules in sequence. This amplification is what makes even small amounts of ROS potentially harmful.

Antioxidants vs oxidants

Cells maintain a redox balance between pro-oxidants and antioxidants. Oxidative stress is, at its core, a failure of this balance.

Endogenous antioxidants

Enzymatic antioxidants form the primary defense:

• Superoxide dismutase (SOD): Converts $O_2^{•-}$ to $H_2O_2$. Different isoforms exist in the cytoplasm (Cu/Zn-SOD), mitochondria (Mn-SOD), and extracellular space.
• Catalase: Converts $H_2O_2$ to $H_2O + O_2$. Found mainly in peroxisomes.
• Glutathione peroxidase (GPx): Also reduces $H_2O_2$, but uses glutathione (GSH) as the electron donor. This links ROS detoxification directly to GSH status.

Non-enzymatic antioxidants include:

• Glutathione (GSH): The most abundant intracellular thiol antioxidant. It directly scavenges radicals and serves as a cofactor for GPx. GSH depletion is a hallmark of severe oxidative stress.
• Uric acid and bilirubin also contribute to plasma antioxidant capacity.

These systems work in a coordinated network. SOD produces $H_2O_2$, which catalase and GPx then eliminate. If one component fails, the whole system is compromised.

Exogenous antioxidants

• Dietary antioxidants like vitamins C and E, carotenoids, and polyphenols supplement endogenous defenses. Vitamin E is particularly important because it's lipid-soluble and can interrupt lipid peroxidation chain reactions in membranes.
• Synthetic antioxidants like N-acetylcysteine (NAC) work by replenishing GSH. NAC is clinically used in acetaminophen overdose specifically because the toxicity mechanism involves GSH depletion.
• Exogenous antioxidants can scavenge free radicals directly, chelate transition metals (preventing Fenton chemistry), and help regenerate endogenous antioxidants.

Balance of antioxidants and oxidants

The redox balance is dynamic. Cells constantly produce ROS through normal metabolism and constantly neutralize them. Oxidative stress tips this balance toward the pro-oxidant side. This can happen through:

• Increased ROS production (e.g., toxicant exposure, inflammation)
• Depletion of antioxidants (e.g., GSH consumption during xenobiotic conjugation)
• Impaired antioxidant enzyme activity (e.g., genetic polymorphisms in SOD or GPx)

Often, multiple factors combine. For example, acetaminophen toxicity involves both increased ROS from the reactive metabolite NAPQI and GSH depletion from NAPQI conjugation.

Cellular effects of oxidative stress

When ROS overwhelm defenses, they damage three major classes of macromolecules: lipids, proteins, and DNA. Each type of damage has distinct consequences.

Lipid peroxidation

ROS attack polyunsaturated fatty acids (PUFAs) in cell membranes because their bis-allylic hydrogens are easily abstracted by radicals. The process unfolds in three stages:

1. Initiation: A radical (often $OH^•$) abstracts a hydrogen from a PUFA, creating a carbon-centered lipid radical.
2. Propagation: The lipid radical reacts with $O_2$ to form a lipid peroxyl radical ($LOO^•$), which abstracts a hydrogen from an adjacent PUFA, generating a new lipid radical. This chain reaction can damage many lipid molecules from a single initiating event.
3. Termination: The chain ends when two radicals react with each other, or when a chain-breaking antioxidant like vitamin E donates a hydrogen to $LOO^•$.

Lipid peroxidation produces reactive aldehydes, notably malondialdehyde (MDA) and 4-hydroxynonenal (4-HNE), which can diffuse from membranes and damage proteins and DNA elsewhere in the cell. Membrane damage alters fluidity and permeability, disrupting ion gradients and receptor function.

Protein oxidation

ROS directly oxidize susceptible amino acid residues, particularly cysteine and methionine (both contain sulfur atoms that are easily oxidized). Consequences include:

• Loss of enzyme activity when active-site residues are modified
• Protein carbonylation (introduction of carbonyl groups), a widely used biomarker of oxidative protein damage
• Disrupted protein-protein interactions
• Protein misfolding and aggregation, which is directly relevant to neurodegenerative diseases like Alzheimer's (amyloid-beta aggregation) and Parkinson's (alpha-synuclein aggregation)

Heavily oxidized proteins are typically targeted for degradation by the proteasome, but if damage is extensive, aggregated proteins can overwhelm this system.

DNA damage

ROS cause several types of DNA lesions:

• Base modifications: The most studied is 8-oxo-deoxyguanosine (8-oxo-dG), formed by oxidation of guanine. It mispairs with adenine during replication, causing G→T transversion mutations.
• Single- and double-strand breaks
• DNA-protein crosslinks

Cells repair oxidative DNA damage primarily through base excision repair (BER), which recognizes and removes damaged bases. However, when damage rates exceed repair capacity, mutations accumulate. Persistent oxidative DNA damage contributes to genomic instability and is a recognized mechanism of chemical carcinogenesis.

Oxidative stress in disease

Oxidative stress isn't just a laboratory concept; it plays a documented role in the pathogenesis of major chronic diseases.

Cardiovascular diseases

Oxidative stress damages the vascular endothelium, reducing nitric oxide bioavailability and promoting vasoconstriction. A key event in atherosclerosis is the oxidation of LDL cholesterol. Oxidized LDL is taken up by macrophages via scavenger receptors (not the normal LDL receptor), leading to foam cell formation and plaque development. This process is not regulated by negative feedback, so macrophages keep accumulating lipid.

Oxidative stress contributes to hypertension, myocardial infarction, and heart failure through endothelial dysfunction and chronic vascular inflammation.

Neurodegenerative disorders

The brain is especially vulnerable to oxidative damage for three reasons:

• High oxygen consumption (~20% of total body $O_2$ use despite being ~2% of body mass)
• High PUFA content in neuronal membranes (susceptible to lipid peroxidation)
• Relatively low antioxidant enzyme levels compared to other tissues

In Alzheimer's disease, oxidative stress promotes amyloid-beta aggregation and tau hyperphosphorylation. In Parkinson's disease, mitochondrial dysfunction in dopaminergic neurons generates excess ROS, contributing to alpha-synuclein aggregation and neuronal death. Oxidative stress also drives neuroinflammation, creating a damaging feedback loop.

Cancer and oxidative stress

The relationship between oxidative stress and cancer is complex and somewhat paradoxical:

• ROS promote carcinogenesis by causing DNA mutations, activating oncogenes (e.g., Ras), and inactivating tumor suppressor genes (e.g., p53).
• Chronic inflammation, a persistent source of ROS, is associated with increased cancer risk in affected tissues (e.g., colorectal cancer in inflammatory bowel disease, liver cancer in chronic hepatitis).
• Once established, cancer cells often have elevated ROS levels but also upregulate antioxidant pathways (particularly through Nrf2) to survive. This adapted redox state supports proliferation and can contribute to therapy resistance.

Measurement of oxidative stress

Measuring oxidative stress in biological systems is essential for research and clinical assessment, but it comes with significant challenges.

Biomarkers of oxidative damage

Since ROS themselves are too short-lived to measure directly in most settings, toxicologists measure the damage they leave behind:

Antioxidant capacity assays

• Total antioxidant capacity (TAC) assays like FRAP (Ferric Reducing Ability of Plasma) and ORAC (Oxygen Radical Absorbance Capacity) measure the overall ability of a sample to neutralize oxidants.
• Individual antioxidant levels (vitamin C, vitamin E, GSH) can be quantified with specific assays.
• Antioxidant enzyme activities (SOD, catalase, GPx) can be measured in tissue or cell extracts.

Challenges in measuring oxidative stress

• ROS have extremely short half-lives ($OH^•$ lasts ~$10^{-9}$ seconds), making direct measurement impractical in most experimental designs.
• Damage biomarkers reflect cumulative injury, not the current redox state. A high 8-oxo-dG level could mean high ongoing damage or impaired repair.
• TAC assays measure antioxidant capacity in a test tube, which may not reflect the compartmentalized reality inside cells (e.g., mitochondrial vs. cytoplasmic redox status).
• Standardization across laboratories remains an ongoing challenge, and no single biomarker captures the full picture of oxidative stress.

Prevention and treatment strategies

Given how central oxidative stress is to toxicant-induced injury, strategies to prevent or mitigate it are a major focus in toxicology.

Dietary antioxidants

A diet rich in fruits and vegetables provides a diverse mix of antioxidants (vitamins C and E, carotenoids, polyphenols) that support endogenous defenses. Specific compounds with demonstrated antioxidant and anti-inflammatory activity include curcumin (turmeric), resveratrol (grapes), and sulforaphane (cruciferous vegetables like broccoli).

Dietary patterns matter more than individual nutrients. The Mediterranean diet, which emphasizes plant-based foods, olive oil, and fish, is consistently associated with reduced biomarkers of oxidative stress and lower chronic disease risk.

Antioxidant supplements

This is an area where the evidence is more nuanced than you might expect. Large clinical trials of high-dose vitamin E and beta-carotene supplementation have generally shown no benefit, and some trials found increased mortality or cancer risk (e.g., the ATBC trial showed increased lung cancer in smokers taking beta-carotene).

The likely explanation is that redox biology is about balance, not simply maximizing antioxidant intake. Excessive antioxidant supplementation can disrupt normal ROS signaling, which cells actually need for functions like apoptosis and immune defense.

Targeted antioxidant therapies are more promising:

• NAC for acetaminophen overdose (replenishes GSH)
• SOD mimetics for specific inflammatory conditions
• Mitochondria-targeted antioxidants (discussed below)

Lifestyle modifications

• Exercise upregulates endogenous antioxidant enzymes (SOD, GPx) through a hormetic mechanism: moderate exercise-induced ROS trigger adaptive antioxidant responses.
• Smoking cessation removes a major exogenous ROS source.
• Reducing alcohol intake lowers hepatic ROS production from CYP2E1.
• Minimizing toxicant exposure (air pollution, occupational chemicals) reduces exogenous oxidative burden.

Current research and future directions

Research in oxidative stress continues to evolve, with a shift toward more targeted and personalized approaches.

Emerging therapeutic targets

• Nrf2 (nuclear factor erythroid 2-related factor 2) is a transcription factor that activates expression of dozens of antioxidant and cytoprotective genes. Nrf2 activators are being developed to boost the cell's own defense systems rather than simply adding exogenous antioxidants.
• Mitochondria-targeted antioxidants like MitoQ and SS-31 (elamipretide) accumulate specifically in mitochondria, addressing ROS at a major production site. This targeted delivery avoids the problems of systemic antioxidant supplementation.
• NOX inhibitors aim to reduce ROS production at specific enzymatic sources, with applications in cardiovascular and neurological diseases.

Antioxidant drug development

• Novel synthetic compounds like bardoxolone methyl (a synthetic triterpenoid Nrf2 activator) are in clinical trials for chronic kidney disease and other conditions.
• Improved delivery strategies, including nanoparticle formulations and prodrug approaches, aim to increase bioavailability and tissue targeting of antioxidant compounds.
• Combination therapies targeting multiple nodes of oxidative stress (ROS production, antioxidant defenses, and damage repair) are being investigated for potential synergistic effects.

Personalized approaches to oxidative stress

Individual variation in oxidative stress susceptibility is substantial. Genetic polymorphisms in antioxidant enzymes (e.g., SOD2, GPx1) can significantly alter an individual's baseline capacity to handle ROS. This means the same toxicant exposure may cause oxidative damage in one person but not another.

Integrating genomics, proteomics, and metabolomics data could eventually enable personalized risk assessment and tailored antioxidant interventions based on an individual's genetic profile, exposure history, and current redox status. This remains an active and rapidly developing area of research.